Skip to main content

Losartan Potassium

NDC 29300-145 · Unichem Pharmaceuticals (USA), Inc.

Generic nameLosartan Potassium
Dosage formTABLET
RouteORAL
Active ingredient(s)LOSARTAN POTASSIUM
Strength50 mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
Marketing categoryANDA

Packages

29300-145-01 — 100 TABLET in 1 BOTTLE, PLASTIC (29300-145-01)

29300-145-10 — 1000 TABLET in 1 BOTTLE, PLASTIC (29300-145-10)

29300-145-13 — 30 TABLET in 1 BOTTLE, PLASTIC (29300-145-13)

29300-145-19 — 90 TABLET in 1 BOTTLE, PLASTIC (29300-145-19)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0904-7047 — Losartan Potassium, 0904-7048 — Losartan Potassium, 0904-7049 — Losartan Potassium, 11788-100 — Losartan Potassium, 11788-101 — Losartan Potassium, 11788-102 — Losartan Potassium, 16714-224 — Losartan Potassium and Hydrochlorothiazide, 16714-225 — Losartan Potassium and Hydrochlorothiazide, 16714-226 — Losartan Potassium and Hydrochlorothiazide, 29300-144 — Losartan Potassium, 29300-146 — Losartan Potassium, 29300-190 — losartan potassium and hydrochlorothiazide, 29300-191 — losartan potassium and hydrochlorothiazide, 29300-192 — losartan potassium and hydrochlorothiazide, 31722-700 — Losartan Potassium, 31722-701 — Losartan Potassium, 31722-702 — Losartan Potassium, 31722-755 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 31722-756 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 31722-757 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, +296 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels